endogenous hormone exposure and genes responsive to such hormones are therefore plausible candidates for being susceptiEndogenous hormone exposure is known to alter breast bility genes. The androgen receptor (AR) and vitamin D cancer susceptibility and genes responsive to such hormones receptor (VDR) are both members of the nuclear receptor are plausible candidates for predisposition genes. We have superfamily which regulate the action of hormone-responsive examined polymorphisms in genes for two members of the genes. They function by binding hormone, androgens or 1,25-nuclear receptor superfamily which are expressed in breast dihydroxyvitamin D, respectively, and then transactivating their tissue and known to moderate rates of cell proliferation in respective hormone-responsive genes via hormone response a case-control association study: the androgen receptor elements in the promotors of the downstream genes. Both (AR) and the vitamin D receptor (VDR). We have used receptors are expressed in breast tissue and are known to two series of Caucasian female breast cancer cases, one moderate rates of cell division. incident and one prevalent, and compared both with two sets of matched controls from the East Anglian region of Missense mutations in the AR have been shown to cause Britain. Since the results are similar in the two series we partial androgen insensitivity (leading to feminization, includhave combined them. The AR poly[Gly] n and poly[Gln] n ing gynaecomastia) together with familial male breast cancer tracts were genotyped in a total of 508 female breast cancer in a few families (3,4). Two of the amino acid substitutions cases and 426 controls. The VDR TaqI polymorphism was implicated, Arg607Gln and Arg608Lys in the DNA-binding analysed in 951 cases and 627 controls drawn from the same domain, reduce the affinity of these mutant ARs for their population series. There were no significant differences response elements and thus their transactivation efficiencies between cases and controls for either the AR or VDR (5) . The AR is expressed in female breast epithelium and polymorphisms. Compared with individuals with two short androgens binding to these receptors inhibit breast cell prolifalleles (<22 repeats) of the AR poly[Gln] n tract, the odds eration (6,7), although AR status in breast tumours is not so ratios and 95% confidence intervals (95% CI) for indistrongly correlated with prognosis as oestrogen receptor and viduals with one or two long alleles were 0.82 (95% progesterone receptor status (8) . CI 0.62-1.09) and 1.31 (95% CI 0.87-1.97), respectively.
Exon 1 of the AR encodes two expressed polymorphic Heterozygotes and homozygotes for the VDR TaqI cutting repeats, a poly[Gly] n and a poly[Gln] n tract. Expansion of the site had odds ratios of 1.01 (95% CI 0.81-1.27) and 0.97 poly[Gln] n tract beyond the normal range of 11-35 repeats (95% CI 0.71-1.32), respectively. None of the AR or VDR causes X-linked spinal-bulbar muscular atrophy (Kennedy's polymorphisms investigated has a major effect on risk of disease) and frequently also mild androgen insensitivity (9) . breast cancer in the British population.
The length of the poly[Gln] n tract has been shown to be inversely related to transactivation efficiency and rate of sperm production (10, 11) . Recently, some studies have suggested an Introduction association of the poly[Gln] n tract with differences in prostate cancer risk: the shorter, more activating, repeat lengths are Breast cancer is a common disease with major public health associated with a mildly increased (1.5-to 2.0-fold) risk of implications. Rare highly penetrant mutations in genes such prostate cancer or an earlier age of onset and possibly also an as BRCA1, BRCA2 and TP53 explain Ͻ5% of total incidence. increased risk of metastasis (12) (13) (14) (15) (16) 
American populations have also suggested associations
The effects of the AR repeats were first assessed by testing for a trend in between certain VDR genotypes and breast cancer risk (27,28).
breast cancer risk with repeat length by fitting a parameter for repeat length
Here we have investigated this association in the British (averaged over the two chromosomes) in logistic regression. We also treated population.
the AR repeats as a di-allelic marker by dividing into long and short repeat lengths using values that have been used in other studies (12, 13, 19, 20 
Results
Anglian region of the UK. Two separate series (Strata) were used to overcome the need to increase thresholds of statistical significance when carrying out 
repeats. Inspection of the individual allele frequencies
The second series were a retrospectively ascertained group of patients reveals no differences between cases and controls greater than corresponding author on request). There is no trend for longer A 9 ml EDTA whole blood sample was taken from each study subject for DNA extraction. DNA was extracted consecutively as the blood samples Table   according to the manufacturer's recommended conditions and using a primer annealing temperature of 57°C in a buffer containing 3:1 deaxa-GTP:GTP to I. Neither heterozygous carriers nor homozygotes for alleles Ͻ22 repeats or Ͼ29 repeats show significant differences in 0.98)], but this result becomes insignificant when the control genotypes are corrected for Hardy-Weinberg equilibrium. breast cancer risk. In series 2 there is some suggestion that the heterozygous carriers of an allele Ͻ22 repeats may be
In contrast to a previous report on a very small sample of males (30), there is no evidence for linkage disequilibrium protected from breast cancer [OR ϭ 0.67 (95% CI 0.46-an increased risk of breast cancer. This became a plausible 
Ͼ29 (l) repeats versus Ͻ28 (s) repeats
We also found no effect of the VDR TaqI RFLP on breast cancer risk in our population sample. We can exclude with breast cancer risk. However, it seems likely that other genes involved in response to endogenous hormones will be more important than these in determining common breast between these two loci: ∆ ϭ -0.09 in controls and 0.017 in cancer risk. cases and neither of these values reaches statistical significance. Vitamin D receptor
